FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3008362893> ?p ?o ?g. }

• W3008362893 endingPage "1537" @default.
• W3008362893 startingPage "1529" @default.
• W3008362893 abstract "Ionizing radiation has historically been used to treat cancer by killing tumour cells, in particular by inducing DNA damage. This view of radiotherapy (RT) as a simple cytotoxic agent has dramatically changed in recent years, and it is now widely accepted that RT can deeply reshape the tumour environment by modulating the immune response. Such evidence gives a strong rationale for the use of immunomodulators to boost the therapeutic value of RT, introducing the era of ‘immunoradiotherapy’. The increasing amount of preclinical and clinical data concerning the combination of RT with immunomodulators, in particular with immune checkpoint inhibitors such as anti‐PD‐1/PD‐L1 and anti‐CTLA4, reflects the interest of the scientific and medical community concerning immunoradiotherapy. The expectations are enormous since the rationale for performing such combinations is strong, with the possibility to use a local treatment such as RT to amplify a systemic antitumour response, as illustrated by the case of the abscopal effect. Nevertheless, several points remain to be addressed such as the need to find biomarkers to identify patients who will benefit from immunoradiotherapy, the identification of the best sequences/schedules for combination with immunomodulators and mechanisms to overcome resistance. Additionally, the effects of immunoradiotherapy on healthy tissues and related toxicity remain largely unexplored. To answer these critical questions and make immunoradiotherapy keep its promising qualities, large efforts are needed from both the pharmaceutical industry and academic/governmental research. Moreover, because of the work of both these entities, the arsenal of available immunomodulators is quickly expanding, thus opening the field to increasing combinations with RT. We thus forecast that the field of immunoradiotherapy will further expand in the coming years, and it needs to be supported by appropriate investment plans." @default.
• W3008362893 created "2020-03-06" @default.
• W3008362893 creator A5013942703 @default.
• W3008362893 creator A5014829112 @default.
• W3008362893 creator A5020234871 @default.
• W3008362893 creator A5084179364 @default.
• W3008362893 creator A5089824447 @default.
• W3008362893 date "2020-03-13" @default.
• W3008362893 modified "2023-10-09" @default.
• W3008362893 title "Radiotherapy–immunotherapy combinations – perspectives and challenges" @default.
• W3008362893 cites W1497172665 @default.
• W3008362893 cites W1943338723 @default.
• W3008362893 cites W1979811833 @default.
• W3008362893 cites W2032166347 @default.
• W3008362893 cites W2052727153 @default.
• W3008362893 cites W2098674394 @default.
• W3008362893 cites W2108789863 @default.
• W3008362893 cites W2127733313 @default.
• W3008362893 cites W2132564070 @default.
• W3008362893 cites W2139758621 @default.
• W3008362893 cites W2140828776 @default.
• W3008362893 cites W2265285917 @default.
• W3008362893 cites W2294024541 @default.
• W3008362893 cites W2471840718 @default.
• W3008362893 cites W2527129822 @default.
• W3008362893 cites W2593996219 @default.
• W3008362893 cites W2615301036 @default.
• W3008362893 cites W2618641368 @default.
• W3008362893 cites W2672652123 @default.
• W3008362893 cites W2744857567 @default.
• W3008362893 cites W2761556077 @default.
• W3008362893 cites W2761681010 @default.
• W3008362893 cites W2763053634 @default.
• W3008362893 cites W2763833914 @default.
• W3008362893 cites W2781765970 @default.
• W3008362893 cites W2787553571 @default.
• W3008362893 cites W2792936363 @default.
• W3008362893 cites W2807947863 @default.
• W3008362893 cites W2883556091 @default.
• W3008362893 cites W2885326465 @default.
• W3008362893 cites W2886091010 @default.
• W3008362893 cites W2891532865 @default.
• W3008362893 cites W2893824814 @default.
• W3008362893 cites W2898394368 @default.
• W3008362893 cites W2899901789 @default.
• W3008362893 cites W2902184592 @default.
• W3008362893 cites W2914362938 @default.
• W3008362893 cites W2914485967 @default.
• W3008362893 cites W2923501617 @default.
• W3008362893 cites W2924762495 @default.
• W3008362893 cites W2956407134 @default.
• W3008362893 cites W2965089489 @default.
• W3008362893 cites W2970683397 @default.
• W3008362893 doi "https://doi.org/10.1002/1878-0261.12658" @default.
• W3008362893 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7332212" @default.
• W3008362893 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32112478" @default.
• W3008362893 hasPublicationYear "2020" @default.
• W3008362893 type Work @default.
• W3008362893 sameAs 3008362893 @default.
• W3008362893 citedByCount "81" @default.
• W3008362893 countsByYear W30083628932020 @default.
• W3008362893 countsByYear W30083628932021 @default.
• W3008362893 countsByYear W30083628932022 @default.
• W3008362893 countsByYear W30083628932023 @default.
• W3008362893 crossrefType "journal-article" @default.
• W3008362893 hasAuthorship W3008362893A5013942703 @default.
• W3008362893 hasAuthorship W3008362893A5014829112 @default.
• W3008362893 hasAuthorship W3008362893A5020234871 @default.
• W3008362893 hasAuthorship W3008362893A5084179364 @default.
• W3008362893 hasAuthorship W3008362893A5089824447 @default.
• W3008362893 hasBestOaLocation W30083628931 @default.
• W3008362893 hasConcept C116834253 @default.
• W3008362893 hasConcept C126322002 @default.
• W3008362893 hasConcept C203014093 @default.
• W3008362893 hasConcept C2777701055 @default.
• W3008362893 hasConcept C2781274730 @default.
• W3008362893 hasConcept C502942594 @default.
• W3008362893 hasConcept C509974204 @default.
• W3008362893 hasConcept C59822182 @default.
• W3008362893 hasConcept C60644358 @default.
• W3008362893 hasConcept C70721500 @default.
• W3008362893 hasConcept C71924100 @default.
• W3008362893 hasConcept C86803240 @default.
• W3008362893 hasConcept C8891405 @default.
• W3008362893 hasConceptScore W3008362893C116834253 @default.
• W3008362893 hasConceptScore W3008362893C126322002 @default.
• W3008362893 hasConceptScore W3008362893C203014093 @default.
• W3008362893 hasConceptScore W3008362893C2777701055 @default.
• W3008362893 hasConceptScore W3008362893C2781274730 @default.
• W3008362893 hasConceptScore W3008362893C502942594 @default.
• W3008362893 hasConceptScore W3008362893C509974204 @default.
• W3008362893 hasConceptScore W3008362893C59822182 @default.
• W3008362893 hasConceptScore W3008362893C60644358 @default.
• W3008362893 hasConceptScore W3008362893C70721500 @default.
• W3008362893 hasConceptScore W3008362893C71924100 @default.
• W3008362893 hasConceptScore W3008362893C86803240 @default.
• W3008362893 hasConceptScore W3008362893C8891405 @default.
• W3008362893 hasFunder F4320320883 @default.

• next